Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (541-550 of 715) with videos related to

Pageof 72
Sort By:
Journal of Internal Medicine|October 1, 1994
Mechanisms of plasminogen activationH R Lijnen, F Bachmann, D Collen, et al.
Thrombosis and Haemostasis|May 24, 2000
Outcome and one year follow-up of intra-arterial staphylokinase in 191 patients with peripheral arterial occlusionS Heymans, S Vanderschueren, R Verhaeghe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Alpha-thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cellsM A Shatos, T Orfeo, J M Doherty, et al.
European Journal of Biochemistry|April 1, 1992
Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinaseA M Vandamme, M Dewerchin, H R Lijnen, et al.
Thrombosis and Haemostasis|March 4, 1991
Fibrinolysis and coagulation in patients with infectious disease and sepsisJ Philippé, F Offner, P J Declerck, et al.
The Journal of Biological Chemistry|April 15, 1993
On the mechanism of the activation of human plasminogen by recombinant staphylokinaseD Collen, B Schlott, Y Engelborghs, et al.
The Journal of Biological Chemistry|September 25, 1989
Characterization of the binding of human tissue-type plasminogen activator to plateletsD E Vaughan, M E Mendelsohn, P J Declerck, et al.
Circulation|April 1, 1987
Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprololF Van de Werf, J Vanhaecke, I K Jang, et al.
Blood|August 15, 1997
Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing miceP Carmeliet, J M Stassen, I Van Vlaenderen, et al.
Journal of Medical Genetics|June 7, 2005
Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association studyD Lambrechts, K Devriendt, D A Driscoll, et al.
Pageof 72

Showing results (541-550 of 715) with videos related to

Sort By:
Pageof 72
Journal of Internal Medicine|October 1, 1994
Mechanisms of plasminogen activationH R Lijnen, F Bachmann, D Collen, et al.
Thrombosis and Haemostasis|May 24, 2000
Outcome and one year follow-up of intra-arterial staphylokinase in 191 patients with peripheral arterial occlusionS Heymans, S Vanderschueren, R Verhaeghe, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 1, 1995
Alpha-thrombin stimulates urokinase production and DNA synthesis in cultured human cerebral microvascular endothelial cellsM A Shatos, T Orfeo, J M Doherty, et al.
European Journal of Biochemistry|April 1, 1992
Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinaseA M Vandamme, M Dewerchin, H R Lijnen, et al.
Thrombosis and Haemostasis|March 4, 1991
Fibrinolysis and coagulation in patients with infectious disease and sepsisJ Philippé, F Offner, P J Declerck, et al.
The Journal of Biological Chemistry|April 15, 1993
On the mechanism of the activation of human plasminogen by recombinant staphylokinaseD Collen, B Schlott, Y Engelborghs, et al.
The Journal of Biological Chemistry|September 25, 1989
Characterization of the binding of human tissue-type plasminogen activator to plateletsD E Vaughan, M E Mendelsohn, P J Declerck, et al.
Circulation|April 1, 1987
Reduction in infarct size and enhanced recovery of systolic function after coronary thrombolysis with tissue-type plasminogen activator combined with beta-adrenergic blockade with metoprololF Van de Werf, J Vanhaecke, I K Jang, et al.
Blood|August 15, 1997
Adenovirus-mediated transfer of tissue-type plasminogen activator augments thrombolysis in tissue-type plasminogen activator-deficient and plasminogen activator inhibitor-1-overexpressing miceP Carmeliet, J M Stassen, I Van Vlaenderen, et al.
Journal of Medical Genetics|June 7, 2005
Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association studyD Lambrechts, K Devriendt, D A Driscoll, et al.
Pageof 72